Close Menu

Tecan

The deal will enable researchers to more easily perform high-throughput, high-density real-time PCR with small, degraded, and hard-to-replace specimens, including formalin-fixed, paraffin-embedded tissue.

Geospiza and NuGen Technologies will combine their informatics and sample-prep products to provide a next- generation sequencing workflow targeted toward large disease research studies.

Under a co-marketing agreement, the companies will combine Geospiza's GeneSifter software with NuGen's Ovation and Encore sample prep reagents.

The deal is aimed at accelerating discoveries for large research studies.

While Biocius' RapidFire technology has traditionally been used by pharma firms for drug-screening work, "one of the key opportunities" Agilent sees is applying the platform "to the clinical proteomics space," a company official said.

New Products: Feb 15, 2011

Premium

Tecan and SciRobotics' Pickolo

At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.

The new product, called the DeepSeq FFPE Solution, runs on the company's RDT 1000 microdroplet PCR instrument and allows researchers to discover rare mutations.

New Products: Feb 8, 2011

Premium

Complete Genomics' sequence data, New England Biolabs' NEBNext, Caliper Life Sciences' TruSeq protocols, CLC Bio and Omixon's Gapped SOLiD Alignment plug-in, DNAnexus' Variation Identification software, Johns Hopkins' Myrna and Crossbow releases

The partners aim to enable automatic processing from a wide range of sample types, such as nucleic acids extracted from sorted cells, fine needle aspirates, formalin-fixed paraffin embedded tissue, and other limited or degraded clinical samples.

Pages

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.